The distribution of gelatinases/matrix metalloproteinases-2 and -9 (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in neonatal and gonadotropin-primed immature rat ovaries was studied by immunofluorescent microscopy. Immature female Long-Evans rats were primed with 15 IU pregnant mare's serum gonadotropin (PMSG) in 100 µl PBS. Two days later, to induce ovulation, the rats were injected with human chorionic gonadotropin (hCG, 5 IU/100 µl PBS). The animals were killed at appropriate times and the ovaries removed and processed for cryostat or paraffin sectioning. Ovaries were also obtained from 7-day-old neonatal rats and processed as above. In the neonatal rat ovary, MMP-2 was present in the follicle and in the ovarian surface epithelium. MMP-9 was not detectable in the neonatal ovary. TIMP-1 was present in the oocyte and in the surface epithelium. In the PMSG-primed ovary, MMP-2 was present in the granulosa and thecal cells of the ovary. MMP-9 distribution, however, was restricted to the interstitial and thecal cells. TIMP-1 was mainly present in the blood vessels and thecal cells, with minor staining in the granulosa cells. In the developing corpus luteum, luteal and endothelial cells were positive for MMP-2. MMP-9 localization was restricted to the plasma membrane of the luteal and interstitial cells. TIMP-1 was clearly observed in the luteal capillaries and, to a lesser extent, in the luteal cell plasma membrane. This distribution of MMP-2, MMP-9, and TIMP-1 in the corpus luteum persisted throughout the life span of the corpus luteum. The spatial and temporal distribution of the gelatinases and TIMP-1 suggests unique roles for these proteins in the rat ovary.
Introduction
Because follicular development and ovulation, and corpus luteum formation and regression, are associated with extensive tissue remodeling, the mammalian ovary provides an excellent model for the study of developmental and regressional events in the adult organism. Both serine proteases (Danø et al. 1985) and matrix metalloproteinases (MMPs) (Birkedal-Hansen et al. 1993) and their respective inhibitors have been shown to regulate homeostatically the extent and rate of extracellular matrix (ECM) reorganization associated with tissue remodeling. These enzymes or their inhibitors have been shown to be present in ovaries of the cow ( Juengel et al. 1994) , hamster (Ichikawa et al. 1983) , human (Curry et al. 1990 , Duncan et al. 1996a , monkey (Duncan et al. 1996b) , mouse (Waterhouse et al. 1993 , Inderdeo et al. 1996 , pig (Smith et al. 1994b) , rabbit (Espey & Coons 1976) , rat (Morales et al. 1983 , Reich et al. 1985 , Curry et al. 1985 , Roche & Ryan 1986 , Hirsch et al. 1993 , Butler & Woessner 1994 , Okada et al. 1994 , Nothnick et al. 1995 , Balbin et al. 1996 , and sheep (Murdoch & McCormick 1992 , Smith et al. 1994a , Russell et al. 1995 , McIntush et al. 1996 . The expression of the metalloproteinases and their inhibitors have been primarily studied by biochemical techniques. Therefore in this study I investigated the distribution of MMP-2, MMP-9 and TIMP-1 in the rat ovary by indirect immunofluorescent microscopy.
Materials and Methods

Animals
All the experiments described in this study conform to the guide for the care and use of laboratory animals published by the National Research Council (Publications No. 0-309-05377-3 1996) and were approved by Kent State University Animal Care and Use Committee. Male and cycling female Long-Evans rats were maintained on regulated photoperiod (12 h light : 12 h darkness cycle) and temperature (24 C); standard rodent chow (Prolabs, St Louis, MO, USA) and water were available ad libitum. Immature female rats for the experiments were obtained by breeding as required.
Immature rat ovary model
Twenty-five-day-old immature female rats were primed with 15 IU pregnant mare's serum gonadotropin (PMSG) (Sigma Chemical Company, St Louis, MO, USA) in 100 µl PBS. Two days later, pseudopregnancy was initiated by injecting the rats with 5 IU of hCG (Sigma Chemical Company, St Louis, MO) in 100 µl of PBS. At chosen times, the animals were killed, and the ovaries were collected for immunofluorescent localization of MMP-2, MMP-9 and TIMP-1. Ovaries for study were also obtained from 7-day-old neonatal rats. Ovaries from at least three animals were studied at each time point. 
Tissue processing and immunofluorescence microscopy
The ovaries were frozen fresh in OCT compound (Lab-Tek Products, Naperville, IL, USA) and 8 µm thick sections were cut in a cryostat set at 15 C. Ovaries were also fixed in Bouin's fixative for 24 h at room temperature, processed for standard paraffin embedding and 6 µm thick sections were cut. Subsequently, before immunostaining, the sections were deparaffinized and incubated with 50 mM ammonium chloride for 10 min to quench aldehyde-induced fluorescence.
For immunostaining, the sections were washed in PBS-0·2% BSA and incubated with PBS-10% BSA for 30 min at 25 C. The PBS-10% BSA was removed and the sections were incubated for 2 h at 25 C or overnight at 4 C with one of the following antibodies in PBS-0·2% BSA: rabbit polyclonal antibodies against human MMP-2 in 1 : 120 dilution (Brown et al. 1990) , human MMP-9 in 1 : 50 dilution (Corcoran et al. 1992) , and human TIMP-1 in 1 : 100 dilution (Ulisse et al. 1994) . Both the MMP-2 and the MMP-9 antibodies (Sreenath et al. 1992 ) and the TIMP-1 antibody (Ulisse et al. 1994) have been shown to cross-react specifically with the rat gelatinases and rat TIMP-1, respectively. Control sections were incubated with normal rabbit serum or 10% BSA in PBS. The sections were then washed and incubated with fluorescein isothiocyanate-conjugated anti-rabbit antibody (Organon Teknika Corporation, Durham, NC, USA) for 30 min at 25 C, washed, and mounted in Vectashield (Vector Laboratories, Burlingame, CA, USA) mounting medium.
Results
Neonatal ovary
The ovaries from the 7-day-old neonatal rats were examined for the presence of MMP-2, MMP-9 and TIMP-1. MMP-2 was widely distributed in the neonatal ovary, especially in the granulosa cells and in the surface epithelium (Fig. 1A) , but MMP-9 was not present in any region of the neonatal ovary (Fig. 1B) . TIMP-1 was localized to the oocyte cytoplasm and the surface epithelium (Fig. 1C) .
Distribution of gelatinases and TIMP-1: 48 h after PMSG
Two days after PMSG injection, numerous preovulatory antral follicles were observed. In these follicles, MMP-2 was localized to the granulosa cells, thecal cells and the interstitium ( Fig. 2A) , although the immunoreactivity was brighter in the thecal and interstitial cells than in the granulosa cells ( Fig. 2A) . MMP-9 distribution was restricted to the thecal and interstitial tissue (Fig. 2B ) and was absent from the granulosa cells of the follicles (Fig. 2B) . TIMP-1 was present predominantly in the thecal cells, along the basement membrane of the follicle, the ovarian surface epithelium, and in the interstitial blood vessels (Fig. 2C, D) .
Distribution of gelatinases and TIMP-1: 10-48 h after hCG
Two days after PMSG injection, hCG was administered to initiate ovulation and subsequent luteinization of the ovulated follicles. When the ovaries were examined around the time of ovulation, MMP-2 was abundantly present in developing luteal cells, actively migrating luteal cells and in the endothelial cells undergoing angiogenesis (Fig. 3A) . Endothelial cells of the interstitium were also stained by the MMP-2 antibody (Fig. 3B) . MMP-9 was present only in the thecal, interstitial and luteal cells of the developing corpus luteum, and the staining was restricted to the plasma membrane of these cells (Fig. 3C, D) . Connective tissue cells, including the endothelial cells in the corpus luteum or in the interstitium, were not positive for MMP-9 (Fig. 3D ). TIMP-1 was closely associated with the developing capillaries of the corpus luteum (Fig. 4A,  B) . No TIMP-1 was present in the luteal cells of the corpus luteum.
Distribution of gelatinases and TIMP-1: 8 and 14 days after hCG
Pseudopregnancy lasts for about 2 weeks after the injection of hCG. On day 8 of pseudopregnancy, when corpora lutea are fully functional, the luteal cells were distinctly stained for MMP-2 (Fig. 5A) . The follicles in the pseudopregnant rat ovary were also stained for MMP-2. Even in day 14 regressing corpora lutea, the luteal cells showed cytoplasmic staining for MMP-2 (Fig. 5B ) and endothelial cells of the capillary were also stained for MMP-2 (Fig.  5B) . In the day 8 ovary, MMP-9 was present, as before, only on the plasma membrane of the luteal cells; no MMP-9 staining could be detected in the follicles (Fig.  5C ). In the regressing corpus luteum, MMP-9 continued to be expressed on the luteal cell membrane (Fig. 5D ).
Endothelial cells of the blood vessels were not stained (Fig.  5D ). TIMP-1 antibody binding was present throughout the pseudopregnancy, including days 8 and 14; binding was restricted to the endothelial basement membrane of luteal capillaries and large vessels (Fig. 6 ).
Discussion
The results of this study show a unique spatial and temporal distribution of the gelatinases (MMP-2 and MMP-9) and TIMP-1 in the rat ovary. This observation of TIMP-1 in the rat oocyte confirms the findings of two earlier studies in which the transcript for this inhibitor was demonstrated in the mouse oocyte (Brenner et al. 1989 , Inderdeo et al. 1996 . Although the significance of TIMP-1 in the oocyte remains unclear, its presence along with collagenase (Bagavandoss et al. 1996) and collagenase and stromelysin (Brenner et al. 1989 ) suggests a potential role for TIMP-1 in ovulation and implantation. In the PMSG-primed ovaries, TIMP-1 was present in the basement membrane of the follicle, thecal cells and the interstitial blood vessels. In some follicles, instead of the oocyte, the zona pellucida was stained for TIMP-1 (not shown). TIMP-1 was only weakly detectable in the granulosa cells of ovaries primed with PMSG or with PMSG and hCG. TIMP-1 was also present in the capillaries of the corpus luteum, interstitial blood vessels and, to some extent, the luteal cell plasma membrane during corpus luteum development, maintenance and regression. However, the presence of TIMP-1 throughout pseudopregnancy does not necessarily imply that it is equally active at all times. As has been shown in the testis, the potency of its activity, for example, may depend on whether or not TIMP-1 is complexed with an existing lysosomal cysteine protease (Boujrad et al. 1995) .
The present observation of TIMP-1 in the theca is in agreement with the presence of its transcript in an earlier study in the rat ovary (Chun et al. 1992) . The lack of TIMP-1 transcript in the follicle and the developing corpus luteum of the cycling mouse ovaries (Inderdeo et al. 1996 ) is intriguing and needs further studies for clarification. Nevertheless, as has been suggested before (Inderdeo et al. 1996) , the expression of TIMP-1 in naturally cycling mouse ovaries may be different from that in the hyperstimulated rat ovaries used in the present study and the earlier study (Chun et al. 1992) . Alternatively, TIMP-1 mRNA could be rapidly degraded after translation in the early corpus luteum. Such a mechanism has been shown to exist for the nuclear proto-oncogene, c-fos (Sassone-Corsi et al. 1988) . Moreover, the presence of 2 -macroglobulin in the absence of detectable mRNA has also been observed in the rat ovary (Gaddy-Kurten et al. 1989) . Nevertheless, when it is present, because TIMP-1 is an inhibitor of endothelial cell migration ( Johnson et al. 1994) , cell-and matrix-bound TIMP-1 may homeostatically regulate the migratory activity of endothelial cells during angiogenesis and angiostasis. The predominant distribution of TIMP-1 along the capillaries in the corpus luteum and other blood vessels is similar to its distribution in the pig corpus luteum (Tanaka et al. 1992) . Unlike the findings in the corpus luteum of the sheep (McIntush et al. 1996) and human (Duncan et al. 1996a) , in which luteal cell cytoplasm was stained for TIMP-1, in the present study TIMP-1 was restricted primarily to the luteal cell membrane. It is not clear if this discrepancy results from species-specific post-translational mechanisms, or from the nature of the method of processing tissues for immunolocalization studies.
In the neonatal ovary, MMP-2 is widely and abundantly distributed. The presence of MMP-2 in the neonatal ovary suggests that this enzyme may be important for follicular development. MMP-2 appears to be the most abundant MMP, as it is strongly expressed in the thecal, interstitial, endothelial, and granulosa cells of the PMSG-primed ovary and in the corpus luteum at all ages. MMP-2 has also been shown by zymography to be the major gelatinase in the rat ovary during the periovulatory period (Curry et al. 1992) and corpus luteum regression (Endo et al. 1993) . However, contrary to the findings of the present in vivo study, in which MMP-2 was found in the granulosa cells, this gelatinase activity could not be demonstrated in the conditioned medium of granulosa cells (Palotie et al. 1987 , Curry et al. 1992 . Whether this discrepancy results from lack of optimal in vitro conditions for the granulosa cell expression of MMP-2 remains to be investigated. MMP-2 is present in the luteal cells of structurally quiescent corpus luteum and in the corpus luteum undergoing active tissue remodeling. Again, the presence of an enzyme is not evidence of its activity, because enzyme activity is modulated by the nature of the ECM (Damsky et al. 1992 , Shapiro et al. 1993 , cell associated integrins (Damsky et al. 1992 , Brooks et al. 1996 and enzyme inhibitors (BirkedalHansen et al. 1992) . Thus the activity of MMP-2 could very well be modulated by metalloproteinase inhibitors (Nothnick et al. 1995) and ECM turnover (Bagavandoss et al. 1983) in the ovary. In addition, it has been shown that progesterone potently inhibits the activity of gelatinases (Marbaix et al. 1992) . Therefore, during pseudopregnancy, changing progesterone concentrations may also modulate the activity of MMP-2.
Unlike MMP-2, which is present in both the neonatal and the hormonally primed ovaries, MMP-9 was present only in the gonadotropin-primed follicles, the interstitium, and the corpus luteum. When it was present, its distribution was restricted to the steroidogenic cells of the theca, interstitium and corpus luteum. Furthermore, it was exclusively localized to the plasma membrane of these cells. The absence of MMP-9 in the neonatal ovaries, granulosa cells and blood vessels suggests that this enzyme may not be important for early follicular development and angiogenesis. Its expression in the luteal cell membrane, however, suggests that MMP-9 may be essential for the organization of these cells in the corpus luteum. This is consistent with the observation that this metalloproteinase transcript is highly expressed on day 1 of pseudopregnancy (Nothnick et al. 1996) . Further, the compartment-specific expression of MMP-9 may be related to the expression of interleukin-1 in the ovary. For example, in vitro, interleukin-1 induces MMP-9 gelatinase in rat thecalinterstitial cells, but not in the granulosa cells (Hurwitz et al. 1993) . During follicular development, interleukin-1 and its receptor type 1 are present only in the thecalinterstitial layer of the rat ovary (Simón et al. 1994) . After ovulation, granulosa lutein cells begin to express this cytokine and its receptor. Collectively, the data suggest that the lack of immunoreactivity for MMP-9 in the granulosa cells of the follicle is probably attributable to the lack of interleukin-1's effect on these cells. As granulosa lutein cells develop a response to interleukin-1, they show staining for MMP-9. The significance of the exclusive plasma membrane localization of MMP-9 is not clear. Nevertheless, gelatinases have previously been localized to the plasma membrane (Brooks et al. 1996 , Partridge et al. 1997 . MMP-9 has also been shown to participate in the invasion of cytotropoblasts (Librach et al. 1991 ). Thus MMP-9 may help in the migration of luteal and interstitial cells during the formation of corpus luteum and interstitial glands respectively. Active MMP-2 has been shown to activate MMP-9 (Fridman et al. 1995) . As MMP-2 is also present in the same cells, this gelatinase may locally regulate the activity of MMP-9. Although MMP-9 is present throughout pseudopregnancy, the activity of this gelatinase may also be regulated by varying concentrations of luteal progesterone (Marbaix et al. 1992) .
In summary, the results of this study indicate that the gelatinases MMP-2 and MMP-9, and TIMP-1 are differentially distributed in the neonatal and gonadotropinprimed rat ovaries before ovulation and during pseudopregnancy. The unique spatial and temporal expression of these proteases and their inhibitor suggests a diverse role for these proteins in follicular development, ovulation and the development, maintenance and regression of the corpus luteum. Hormonal regulation and tissue-specific localization of
